Testing effectiveness (Phase 2)WithdrawnNCT02378623
What this trial is testing
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
Who this might be right for
Patent Foramen OvaleCardiac Implantable Electronic Device
Mayo Clinic